Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French “real-world” prospective GARO Registry
Authors:
- 5 November 2015
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 203, 690-696
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2014
- Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiographyHeart, 2013
- A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosisAmerican Heart Journal, 2013
- Drug-Eluting Coronary-Artery StentsNew England Journal of Medicine, 2013
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysisThe Lancet, 2012
- Long-Term Follow-Up After Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon CatheterJACC: Cardiovascular Interventions, 2012
- Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent RestenosisCirculation, 2009
- Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheterClinical Research in Cardiology, 2008
- A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label IndicationsNew England Journal of Medicine, 2008
- Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon CatheterNew England Journal of Medicine, 2006